These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1270740)

  • 1. Warfarin.
    Benya TJ; Adler DS; Bates TR
    J Am Pharm Assoc; 1976 May; 16(5):271-4. PubMed ID: 1270740
    [No Abstract]   [Full Text] [Related]  

  • 2. Warfarin pharmacokinetics in the horse.
    Thijssen HH; van den Bogaard AE; Wetzel JM; Maes JH; Muller AP
    Am J Vet Res; 1983 Jul; 44(7):1192-6. PubMed ID: 6881659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The negative impact of biological variation in the effect and clearance of warfarin on methods for prediction of dose requirements.
    Weiss P; Halkin H; Almog S
    Thromb Haemost; 1986 Dec; 56(3):371-5. PubMed ID: 3563968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin pharmacogenomics: a big step forward for individualized medicine: enlightened dosing of warfarin.
    Elias DJ; Topol EJ
    Eur J Hum Genet; 2008 May; 16(5):532-4. PubMed ID: 18301451
    [No Abstract]   [Full Text] [Related]  

  • 5. Smoking and warfarin dosage.
    Mitchell AA
    N Engl J Med; 1972 Nov; 287(22):1153-4. PubMed ID: 5082209
    [No Abstract]   [Full Text] [Related]  

  • 6. Warfarin metabolites: the anticoagulant activity and pharmacology of warfarin alcohols.
    Lewis RJ; Trager WF; Robinson AJ; Chan KK
    J Lab Clin Med; 1973 Jun; 81(6):925-31. PubMed ID: 4710371
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interaction between warfarin and coenzyme Q10].
    Landbo C; Almdal TP
    Ugeskr Laeger; 1998 May; 160(22):3226-7. PubMed ID: 9621803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of warfarin during methandrostenolone treatment.
    Pyörälä K; Myllylä G; Kekki M
    Ann Med Exp Biol Fenn; 1965; 43(2):95-7. PubMed ID: 5317992
    [No Abstract]   [Full Text] [Related]  

  • 9. Warfarin metabolism in man: identification of metabolites in urine.
    Lewis RJ; Trager WF
    J Clin Invest; 1970 May; 49(5):907-13. PubMed ID: 5441544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The distribution of warfarin (Coumadin) in the rat.
    Anderson GF
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):754-8. PubMed ID: 5590254
    [No Abstract]   [Full Text] [Related]  

  • 11. A model solution for intestinal absorption of warfarin. A drug with non-linear distribution pharmacokinetics in the rat.
    Julkunen RJ; Kekki M; Wahlström B
    Arzneimittelforschung; 1980; 30(2):264-7. PubMed ID: 7378103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption of warfarin from the stomach and small intestine.
    Pyörälä K; Jussila J; Mustala O; Siurala M
    Scand J Gastroenterol Suppl; 1971; 9():95-103. PubMed ID: 5284153
    [No Abstract]   [Full Text] [Related]  

  • 13. 14 C-warfarin excretion in the rat.
    Losito R; Rousseau MA
    Thromb Diath Haemorrh; 1972 Apr; 27(2):300-8. PubMed ID: 4558992
    [No Abstract]   [Full Text] [Related]  

  • 14. Current concepts of warfarin therapy.
    Peterson CE; Kwaan HC
    Arch Intern Med; 1986 Mar; 146(3):581-4. PubMed ID: 3513725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of oxyphenbutazone on the excretion of 14 C-warfarin in the bile of rat.
    Wosilait WD; Eisenbrandt LL
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):413-20. PubMed ID: 5074533
    [No Abstract]   [Full Text] [Related]  

  • 16. [Interaction between warfarin and nalidic acid].
    Gulløv AL; Koefoed BG; Petersen P
    Ugeskr Laeger; 1996 Sep; 158(37):5174-5. PubMed ID: 8848852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No effect of encapsulation on the pharmacokinetics of warfarin.
    Johansson S; Ohlsson L; Stenhoff H; Wåhlander K; Cullberg M
    Biopharm Drug Dispos; 2005 Apr; 26(3):121-7. PubMed ID: 15751004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pain relief in patients treated with Waran].
    Niklasson A; Andrén L
    Lakartidningen; 2006 Apr 26-May 2; 103(17):1334-5. PubMed ID: 16708863
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic side-effects and interactions.
    Walan A
    Scand J Gastroenterol Suppl; 1982; 75():63-8. PubMed ID: 6183731
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of phenobarbital and glutethimide on biological half-life of warfarin.
    Corn M
    Thromb Diath Haemorrh; 1966 Dec; 16(3):606-12. PubMed ID: 5996677
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.